IE872694L - Factor ix-peptides - Google Patents

Factor ix-peptides

Info

Publication number
IE872694L
IE872694L IE872694A IE269487A IE872694L IE 872694 L IE872694 L IE 872694L IE 872694 A IE872694 A IE 872694A IE 269487 A IE269487 A IE 269487A IE 872694 L IE872694 L IE 872694L
Authority
IE
Ireland
Prior art keywords
asp
gln
gly
tyr
lys
Prior art date
Application number
IE872694A
Original Assignee
Bandag Licensing Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bandag Licensing Corp filed Critical Bandag Licensing Corp
Publication of IE872694L publication Critical patent/IE872694L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/644Coagulation factor IXa (3.4.21.22)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6432Coagulation factor Xa (3.4.21.6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21006Coagulation factor Xa (3.4.21.6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21022Coagulation factor IXa (3.4.21.22)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to polypeptides which contain the EGF domain of factor IX or a subsequence thereof and are suitable for the specific inhibition of the binding of coagulation factor IX or its activated form IXa to endothelial cell surfaces. The invention also relates to pharmaceutical products which contain such polypeptides. The polypeptides and the pharmaceutical products make it possible to treat thrombotic disorders without impairing the protective extravascular coagulation and comprise the following amino-acid sequences: Asp-Gly-Asp-Gln-Cys, Lys-Gln-Tyr-Val-Asp-Gly-Asp-Gln-Cys, Phe-Trp-Lys-Gln-Tyr-Val-Asp-Gly-Asp-Gln-NH2, Lys-Gln-Tyr-Val-Asp-Gly-Asp-Gln-Cys-Glu-Ser-Asn-NH2 and Lys-Gln-Tyr-Val-Asp-Gly-Asp-Gln-NH2. [EP0263529A1]
IE872694A 1986-10-09 1987-10-08 Factor ix-peptides IE872694L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91677386A 1986-10-09 1986-10-09
US93058886A 1986-11-13 1986-11-13
US8332287A 1987-08-10 1987-08-10

Publications (1)

Publication Number Publication Date
IE872694L true IE872694L (en) 1988-04-09

Family

ID=27374504

Family Applications (1)

Application Number Title Priority Date Filing Date
IE872694A IE872694L (en) 1986-10-09 1987-10-08 Factor ix-peptides

Country Status (6)

Country Link
EP (1) EP0263529A1 (en)
AU (1) AU607714B2 (en)
DK (1) DK525787A (en)
IE (1) IE872694L (en)
IL (1) IL84126A0 (en)
NZ (1) NZ222084A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4403057C1 (en) * 1994-02-02 1994-12-08 Biotest Pharma Gmbh Platelet-stabilising factor IX fragments, the preparation thereof and pharmaceutical compositions containing them
DE4435520A1 (en) * 1994-10-04 1996-04-11 Immuno Ag Process for the separation of recombinant pro-factor IX from recombinant factor IX

Also Published As

Publication number Publication date
AU7948187A (en) 1988-04-14
DK525787A (en) 1988-04-10
EP0263529A1 (en) 1988-04-13
IL84126A0 (en) 1988-03-31
AU607714B2 (en) 1991-03-14
DK525787D0 (en) 1987-10-07
NZ222084A (en) 1991-06-25

Similar Documents

Publication Publication Date Title
EP1175909A3 (en) Therapeutic methods and compositions based on serrate proteins and nucleic acids
EP0935963A3 (en) The use of MMP-13 selective inhibitors for the treatment of osteoarthritis and other matrix metalloproteinase-mediated disorders
IE891798L (en) Novel ó-glucosidase inhibitors
BG103977A (en) Low molecular rotamase enzymic activity inhibitors
EP0374440A3 (en) Inhibitors of lysyl oxidase
WO2001079464A3 (en) Nucleic acids encoding polypeptides having haloperoxidase activity
DE3689195D1 (en) Process for the production of aloe products, products and compositions therefor.
EP1652931A3 (en) Recombinant adenoviruses, preparation and uses thereof for the treatment and/or prevention ofs cancers
EP0308937A3 (en) Activated aluminum chloride hydroxide
NZ215096A (en) Renin inhibiting peptide derivatives, pepstatin analogues
BG104267A (en) Aminoterminally incised rantes as haemokin antagonists
AR244544A1 (en) Amino acid beta-lyase enzyme inhibitors as deodorants
EP0220107A3 (en) Use of angiotensin-converting enzyme inhibitors in macular degeneration
EP0319315A3 (en) The von willebrand factor binding domain of factor viii
AU4218389A (en) Peptide compounds
TW369541B (en) Thrombin inhibitors
IE872694L (en) Factor ix-peptides
DK270489D0 (en) PROTEIN WITH THROMBIN INHIBITIVE EFFECTS, PROCEDURE FOR ITS INSULATION, AND ITS USE AS A MEDICINE
EP0576915A3 (en) Cyclopentanperhydrophenanthren-17beta-(3-furyl)-3-derivatives and pharmaceutical compositions comprising same for the treatment of cardiovascular disorders
EP0104546A3 (en) Therapeutic dipeptides
IE902276L (en) Serpin variants
AR240485A1 (en) ACTIVATING COMPOSITIONS, EXEMPTED FROM TITANIUM, PROCEDURE TO OBTAIN THEM AND PROCEDURE TO ACTIVATE METALLIC SURFACES PRIOR TO THEIR PHOSPHATATION TO THE ZIONC USING SUCH PHOSPHATES.
DE68911908D1 (en) METHOD FOR DELAYING THE OLD BAKING OF BAKING PRODUCTS.
DK0412951T3 (en) Peptides that block cell adhesion to S-alminin
WO1998018818A3 (en) Hepatitis b inhibitors